Bioburden Testing Market, Global Outlook and Forecast 2022-2028

April 2022 | 62 pages | ID: B96B3EE7CB6EEN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Bioburden Testing in Global, including the following market information:

Global Bioburden Testing Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Bioburden Testing market was valued at 571.8 million in 2021 and is projected to reach US$ 902 million by 2028, at a CAGR of 6.7% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Instruments Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Bioburden Testing include Charles River Laboratories International, Sigma-Aldrich, SGS, Wuxi Pharmatech (CAYMAN), Merck, Becton Dickinson, North American Science Associates Inc., Nelson Laboratories and Pacific Biolabs and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Bioburden Testing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Bioburden Testing Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Bioburden Testing Market Segment Percentages, by Type, 2021 (%)

• Instruments
• Consumables

Global Bioburden Testing Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Bioburden Testing Market Segment Percentages, by Application, 2021 (%)

• Pharmaceutical
• Biotechnology

Global Bioburden Testing Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Bioburden Testing Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Bioburden Testing revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Bioburden Testing revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Charles River Laboratories International
• Sigma-Aldrich
• SGS
• Wuxi Pharmatech (CAYMAN)
• Merck
• Becton Dickinson
• North American Science Associates Inc.
• Nelson Laboratories
• Pacific Biolabs
• ATS Labs

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Bioburden Testing Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Bioburden Testing Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL BIOBURDEN TESTING OVERALL MARKET SIZE

2.1 Global Bioburden Testing Market Size: 2021 VS 2028
2.2 Global Bioburden Testing Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Bioburden Testing Players in Global Market
3.2 Top Global Bioburden Testing Companies Ranked by Revenue
3.3 Global Bioburden Testing Revenue by Companies
3.4 Top 3 and Top 5 Bioburden Testing Companies in Global Market, by Revenue in 2021
3.5 Global Companies Bioburden Testing Product Type
3.6 Tier 1, Tier 2 and Tier 3 Bioburden Testing Players in Global Market
  3.6.1 List of Global Tier 1 Bioburden Testing Companies
  3.6.2 List of Global Tier 2 and Tier 3 Bioburden Testing Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Bioburden Testing Market Size Markets, 2021 & 2028
  4.1.2 Instruments
  4.1.3 Consumables
4.2 By Type - Global Bioburden Testing Revenue & Forecasts
  4.2.1 By Type - Global Bioburden Testing Revenue, 2017-2022
  4.2.2 By Type - Global Bioburden Testing Revenue, 2023-2028
  4.2.3 By Type - Global Bioburden Testing Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Bioburden Testing Market Size, 2021 & 2028
  5.1.2 Pharmaceutical
  5.1.3 Biotechnology
5.2 By Application - Global Bioburden Testing Revenue & Forecasts
  5.2.1 By Application - Global Bioburden Testing Revenue, 2017-2022
  5.2.2 By Application - Global Bioburden Testing Revenue, 2023-2028
  5.2.3 By Application - Global Bioburden Testing Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Bioburden Testing Market Size, 2021 & 2028
6.2 By Region - Global Bioburden Testing Revenue & Forecasts
  6.2.1 By Region - Global Bioburden Testing Revenue, 2017-2022
  6.2.2 By Region - Global Bioburden Testing Revenue, 2023-2028
  6.2.3 By Region - Global Bioburden Testing Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Bioburden Testing Revenue, 2017-2028
  6.3.2 US Bioburden Testing Market Size, 2017-2028
  6.3.3 Canada Bioburden Testing Market Size, 2017-2028
  6.3.4 Mexico Bioburden Testing Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Bioburden Testing Revenue, 2017-2028
  6.4.2 Germany Bioburden Testing Market Size, 2017-2028
  6.4.3 France Bioburden Testing Market Size, 2017-2028
  6.4.4 U.K. Bioburden Testing Market Size, 2017-2028
  6.4.5 Italy Bioburden Testing Market Size, 2017-2028
  6.4.6 Russia Bioburden Testing Market Size, 2017-2028
  6.4.7 Nordic Countries Bioburden Testing Market Size, 2017-2028
  6.4.8 Benelux Bioburden Testing Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Bioburden Testing Revenue, 2017-2028
  6.5.2 China Bioburden Testing Market Size, 2017-2028
  6.5.3 Japan Bioburden Testing Market Size, 2017-2028
  6.5.4 South Korea Bioburden Testing Market Size, 2017-2028
  6.5.5 Southeast Asia Bioburden Testing Market Size, 2017-2028
  6.5.6 India Bioburden Testing Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Bioburden Testing Revenue, 2017-2028
  6.6.2 Brazil Bioburden Testing Market Size, 2017-2028
  6.6.3 Argentina Bioburden Testing Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Bioburden Testing Revenue, 2017-2028
  6.7.2 Turkey Bioburden Testing Market Size, 2017-2028
  6.7.3 Israel Bioburden Testing Market Size, 2017-2028
  6.7.4 Saudi Arabia Bioburden Testing Market Size, 2017-2028
  6.7.5 UAE Bioburden Testing Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Charles River Laboratories International
  7.1.1 Charles River Laboratories International Corporate Summary
  7.1.2 Charles River Laboratories International Business Overview
  7.1.3 Charles River Laboratories International Bioburden Testing Major Product Offerings
  7.1.4 Charles River Laboratories International Bioburden Testing Revenue in Global Market (2017-2022)
  7.1.5 Charles River Laboratories International Key News
7.2 Sigma-Aldrich
  7.2.1 Sigma-Aldrich Corporate Summary
  7.2.2 Sigma-Aldrich Business Overview
  7.2.3 Sigma-Aldrich Bioburden Testing Major Product Offerings
  7.2.4 Sigma-Aldrich Bioburden Testing Revenue in Global Market (2017-2022)
  7.2.5 Sigma-Aldrich Key News
7.3 SGS
  7.3.1 SGS Corporate Summary
  7.3.2 SGS Business Overview
  7.3.3 SGS Bioburden Testing Major Product Offerings
  7.3.4 SGS Bioburden Testing Revenue in Global Market (2017-2022)
  7.3.5 SGS Key News
7.4 Wuxi Pharmatech (CAYMAN)
  7.4.1 Wuxi Pharmatech (CAYMAN) Corporate Summary
  7.4.2 Wuxi Pharmatech (CAYMAN) Business Overview
  7.4.3 Wuxi Pharmatech (CAYMAN) Bioburden Testing Major Product Offerings
  7.4.4 Wuxi Pharmatech (CAYMAN) Bioburden Testing Revenue in Global Market (2017-2022)
  7.4.5 Wuxi Pharmatech (CAYMAN) Key News
7.5 Merck
  7.5.1 Merck Corporate Summary
  7.5.2 Merck Business Overview
  7.5.3 Merck Bioburden Testing Major Product Offerings
  7.5.4 Merck Bioburden Testing Revenue in Global Market (2017-2022)
  7.5.5 Merck Key News
7.6 Becton Dickinson
  7.6.1 Becton Dickinson Corporate Summary
  7.6.2 Becton Dickinson Business Overview
  7.6.3 Becton Dickinson Bioburden Testing Major Product Offerings
  7.6.4 Becton Dickinson Bioburden Testing Revenue in Global Market (2017-2022)
  7.6.5 Becton Dickinson Key News
7.7 North American Science Associates Inc.
  7.7.1 North American Science Associates Inc. Corporate Summary
  7.7.2 North American Science Associates Inc. Business Overview
  7.7.3 North American Science Associates Inc. Bioburden Testing Major Product Offerings
  7.7.4 North American Science Associates Inc. Bioburden Testing Revenue in Global Market (2017-2022)
  7.7.5 North American Science Associates Inc. Key News
7.8 Nelson Laboratories
  7.8.1 Nelson Laboratories Corporate Summary
  7.8.2 Nelson Laboratories Business Overview
  7.8.3 Nelson Laboratories Bioburden Testing Major Product Offerings
  7.8.4 Nelson Laboratories Bioburden Testing Revenue in Global Market (2017-2022)
  7.8.5 Nelson Laboratories Key News
7.9 Pacific Biolabs
  7.9.1 Pacific Biolabs Corporate Summary
  7.9.2 Pacific Biolabs Business Overview
  7.9.3 Pacific Biolabs Bioburden Testing Major Product Offerings
  7.9.4 Pacific Biolabs Bioburden Testing Revenue in Global Market (2017-2022)
  7.9.5 Pacific Biolabs Key News
7.10 ATS Labs
  7.10.1 ATS Labs Corporate Summary
  7.10.2 ATS Labs Business Overview
  7.10.3 ATS Labs Bioburden Testing Major Product Offerings
  7.10.4 ATS Labs Bioburden Testing Revenue in Global Market (2017-2022)
  7.10.5 ATS Labs Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Bioburden Testing Market Opportunities & Trends in Global Market
Table 2. Bioburden Testing Market Drivers in Global Market
Table 3. Bioburden Testing Market Restraints in Global Market
Table 4. Key Players of Bioburden Testing in Global Market
Table 5. Top Bioburden Testing Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Bioburden Testing Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Bioburden Testing Revenue Share by Companies, 2017-2022
Table 8. Global Companies Bioburden Testing Product Type
Table 9. List of Global Tier 1 Bioburden Testing Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Bioburden Testing Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Bioburden Testing Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Bioburden Testing Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Bioburden Testing Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Bioburden Testing Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Bioburden Testing Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Bioburden Testing Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Bioburden Testing Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Bioburden Testing Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Bioburden Testing Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Bioburden Testing Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Bioburden Testing Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Bioburden Testing Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Bioburden Testing Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Bioburden Testing Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Bioburden Testing Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Bioburden Testing Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Bioburden Testing Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Bioburden Testing Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Bioburden Testing Revenue, (US$, Mn), 2023-2028
Table 30. Charles River Laboratories International Corporate Summary
Table 31. Charles River Laboratories International Bioburden Testing Product Offerings
Table 32. Charles River Laboratories International Bioburden Testing Revenue (US$, Mn), (2017-2022)
Table 33. Sigma-Aldrich Corporate Summary
Table 34. Sigma-Aldrich Bioburden Testing Product Offerings
Table 35. Sigma-Aldrich Bioburden Testing Revenue (US$, Mn), (2017-2022)
Table 36. SGS Corporate Summary
Table 37. SGS Bioburden Testing Product Offerings
Table 38. SGS Bioburden Testing Revenue (US$, Mn), (2017-2022)
Table 39. Wuxi Pharmatech (CAYMAN) Corporate Summary
Table 40. Wuxi Pharmatech (CAYMAN) Bioburden Testing Product Offerings
Table 41. Wuxi Pharmatech (CAYMAN) Bioburden Testing Revenue (US$, Mn), (2017-2022)
Table 42. Merck Corporate Summary
Table 43. Merck Bioburden Testing Product Offerings
Table 44. Merck Bioburden Testing Revenue (US$, Mn), (2017-2022)
Table 45. Becton Dickinson Corporate Summary
Table 46. Becton Dickinson Bioburden Testing Product Offerings
Table 47. Becton Dickinson Bioburden Testing Revenue (US$, Mn), (2017-2022)
Table 48. North American Science Associates Inc. Corporate Summary
Table 49. North American Science Associates Inc. Bioburden Testing Product Offerings
Table 50. North American Science Associates Inc. Bioburden Testing Revenue (US$, Mn), (2017-2022)
Table 51. Nelson Laboratories Corporate Summary
Table 52. Nelson Laboratories Bioburden Testing Product Offerings
Table 53. Nelson Laboratories Bioburden Testing Revenue (US$, Mn), (2017-2022)
Table 54. Pacific Biolabs Corporate Summary
Table 55. Pacific Biolabs Bioburden Testing Product Offerings
Table 56. Pacific Biolabs Bioburden Testing Revenue (US$, Mn), (2017-2022)
Table 57. ATS Labs Corporate Summary
Table 58. ATS Labs Bioburden Testing Product Offerings
Table 59. ATS Labs Bioburden Testing Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Bioburden Testing Segment by Type in 2021
Figure 2. Bioburden Testing Segment by Application in 2021
Figure 3. Global Bioburden Testing Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Bioburden Testing Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Bioburden Testing Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Bioburden Testing Revenue in 2021
Figure 8. By Type - Global Bioburden Testing Revenue Market Share, 2017-2028
Figure 9. By Application - Global Bioburden Testing Revenue Market Share, 2017-2028
Figure 10. By Region - Global Bioburden Testing Revenue Market Share, 2017-2028
Figure 11. By Country - North America Bioburden Testing Revenue Market Share, 2017-2028
Figure 12. US Bioburden Testing Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Bioburden Testing Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Bioburden Testing Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Bioburden Testing Revenue Market Share, 2017-2028
Figure 16. Germany Bioburden Testing Revenue, (US$, Mn), 2017-2028
Figure 17. France Bioburden Testing Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Bioburden Testing Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Bioburden Testing Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Bioburden Testing Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Bioburden Testing Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Bioburden Testing Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Bioburden Testing Revenue Market Share, 2017-2028
Figure 24. China Bioburden Testing Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Bioburden Testing Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Bioburden Testing Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Bioburden Testing Revenue, (US$, Mn), 2017-2028
Figure 28. India Bioburden Testing Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Bioburden Testing Revenue Market Share, 2017-2028
Figure 30. Brazil Bioburden Testing Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Bioburden Testing Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Bioburden Testing Revenue Market Share, 2017-2028
Figure 33. Turkey Bioburden Testing Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Bioburden Testing Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Bioburden Testing Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Bioburden Testing Revenue, (US$, Mn), 2017-2028
Figure 37. Charles River Laboratories International Bioburden Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Sigma-Aldrich Bioburden Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. SGS Bioburden Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Wuxi Pharmatech (CAYMAN) Bioburden Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Merck Bioburden Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Becton Dickinson Bioburden Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. North American Science Associates Inc. Bioburden Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Nelson Laboratories Bioburden Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Pacific Biolabs Bioburden Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. ATS Labs Bioburden Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)